Integrative research means our extensive company research informs every thesis and perspective. The result is deep industry knowledge, expertise, and trend insights that yield valuable results for our partners and clients.

About the Authors:
Joseph Munda
Senior Vice President
Joe Munda has worked in finance and investment for 17 years and joined First Analysis in 2015. He works with entrepreneurs as an investor and as an advisor on growth transactions to help build leading businesses in healthcare technology. He has played a key role in building First Analysis’ franchises in drug development technology and medical technology and has published several thought-leading white papers in those areas. He supports First Analysis' investments in Checkpoint Surgical, Medicinal Genomics, Transformative Pharmaceutical Solutions, VIDA Diagnostics and Yunu. Prior to joining First Analysis, he was an equity research analyst covering medical device and healthcare services companies at Sidoti & Co. Earlier, he worked in institutional sales at Bear Stearns/J.P. Morgan. He earned a bachelor's degree in finance from Fairleigh Dickinson University.
Walid Elmekki
Senior Associate
Walid Elmekki is a senior analyst with First Analysis. Walid joined the firm in 2021 after completing his internship. He previously interned at Wintrust Financial supporting the commercial banking division. Walid graduated from Ohio State University with a bachelor’s degree in finance and a certificate of leadership.
First Analysis Pharma IT Team
Joseph Munda
Senior Vice President
Matthew Nicklin
Managing Director
Tracy Marshbanks
Managing Director
Andrew Walsh
Managing Director
Walid Elmekki
Senior Associate
First Analysis Quarterly Insights
Pharma IT
Clinical trial supply challenges create opportunity for tech
November 3, 2023
  • Clinical trial supply chains are deeply interconnected. However, teams throughout the process often work in silos, making clinical trial supply management extremely complex and difficult.
  • Given the pivotal role of supply chains in patient safety, clinical trial efficiency and overall trial success, pharmaceutical companies are increasingly focused on improving supply chain management, most notably by making greater use of supply chain software.
  • We examine four areas where clinical trial supply chain management software is having a high-profile impact: randomization and trial supply management and forecasting, sample management, condition monitoring, and cell and gene therapy. We also profile some of the technology solutions innovative companies offer in each of these areas.


Includes discussion of six private companies

Pandemic experiences highlighted the need to address trial supply challenges

Multiple pain points in supplying clinical trials

Randomization and trial supply management and forecasting

Sample management

Condition monitoring

Cell and gene therapy

Advanced technology meeting the needs of advanced therapeutics

Commercialization index in line with markets; eClinical far behind

Pharma IT M&A: Notable transactions include CorEvitas and Clario

Pharma IT private placements: Notable transactions include Clinetic, QuantHealth

Pandemic experiences highlighted the need to address trial supply challenges

Clinical trials are the backbone of medical research, serving as a key bridge between drug development and patient care. As we have discussed in our previous reports, clinical trials are expensive and time consuming, and any delay pushes out the timeline for potential approval, meaning lost opportunities to improve patients' lives and unrecoverable revenue. Supplying clinical trials with trial therapies, or investigational medicinal products (IMPs), is a pivotal part of the clinical trial process that can affect trials' success, cost and speed. The critical nature of clinical trial supply management became especially apparent during the pandemic, which highlighted supply chain weaknesses in areas such as third-party logistics, forecasting, inventory visibility and staffing. With this in mind, pharmaceutical companies are increasingly turning to technology-based solution providers to handle some or all of their clinical trial supply needs.

Multiple pain points in supplying clinical trials

Clinical trial supplies are the investigational medicinal products and other materials and equipment needed to effectively conduct clinical trials. This includes everything from drugs being tested to patient biological samples to the packaging and labeling used in moving them from one location to another. Managing clinical trial supplies involves a range of activities, from planning and forecasting to procurement and distribution. Clinical trial supply chains are deeply interconnected. Expected enrollment levels at trial sites affect supply and logistics decisions made upstream. Unfortunately, most teams throughout the process work in silos, making clinical trial supply management extremely complex and difficult with challenges that include managing inventory levels, ensuring timely delivery of investigational drugs, and maintaining regulatory compliance and patient safety.

To access the full report, please provide your contact information in the form below. A First Analysis representative will follow up with you shortly. Thanks for your interest in First Analysis research.
First Name required!
Last Name required!
Email required!
Industry required!
Unfortunately, your request to access the complete report has failed.

Please check the contact information you have entered.

If the form submission failure persists, please contact Person at (xxx) xxx-xxxx to handle your request. Thank you.
©2024 by First Analysis Corporation.
One South Wacker Drive
Suite 3900
Chicago, IL 60606